Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

Summary

This study is being done to evaluate the safety and effectiveness of alagebrium in subjects diagnosed with diastolic heart failure. The primary assessment for effectiveness is the assessment of exercise tolerance.

Timeline

Start

2008-03

Primary completion

2009-10

Completion

2009-12

Outcome

Outcome not reported

Stopped (Business): “Study has been terminated early due to financial constraints.”

Drugs

Indications